Insider Transactions in Q1 2022 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2022
|
Andrew A. F. Hack |
BUY
Open market or private purchase
|
Indirect |
1,136,363
+14.84%
|
$4,545,452
$4.42 P/Share
|
|
Jan 18
2022
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,982
-37.03%
|
$9,910
$5.92 P/Share
|
|
Jan 18
2022
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,741
-3.49%
|
$23,705
$5.92 P/Share
|
|
Jan 14
2022
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,208
+36.74%
|
-
|
|
Jan 14
2022
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,958
+10.77%
|
-
|
|
Jan 14
2022
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,353
+50.0%
|
-
|
|
Jan 14
2022
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,209
+10.06%
|
-
|